Amedeo's Top 20

Amedeo Smart

Independent Medical Education

25 September 2017

Multidisciplinary Journal Club

  1. Xie YL, Chakravorty S, Armstrong DT, Hall SL, et al.
    Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.
    N Engl J Med 2017;377:1043-1054.

  1. Wolchok JD, Chiarion-Sileni V, Gonzalez R, Rutkowski P, et al.
    Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
    N Engl J Med 2017.

  2. Weber J, Mandala M, Del Vecchio M, Gogas HJ, et al.
    Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma.
    N Engl J Med 2017.

  3. Blasco B, Leroy D, Fidock DA.
    Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic.
    Nat Med 2017;23:917-928.

  4. Long GV, Hauschild A, Santinami M, Atkinson V, et al.
    Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma.
    N Engl J Med 2017.

  1. Giuliano AE, Ballman KV, McCall L, Beitsch PD, et al.
    Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
    JAMA 2017;318:918-926.

  2. Saag KG, Petersen J, Brandi ML, Karaplis AC, et al.
    Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis.
    N Engl J Med 2017.

  3. Holman RR, Bethel MA, Mentz RJ, Thompson VP, et al.
    Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med 2017.

  4. Mancuso JD, Mody RM, Olsen CH, Harrison LH, et al.
    The Long-term Effect of Bacille Calmette-Guerin Vaccination on Tuberculin Skin Testing: A 55-Year Follow-Up Study.
    Chest 2017;152:282-294.

  5. Carr TF, Zeki AA, Kraft M.
    Eosinophilic and Non-Eosinophilic Asthma.
    Am J Respir Crit Care Med 2017.

  1. Mann JFE, Orsted DD, Brown-Frandsen K, Marso SP, et al.
    Liraglutide and Renal Outcomes in Type 2 Diabetes.
    N Engl J Med 2017;377:839-848.

  2. Mas JL, Derumeaux G, Guillon B, Massardier E, et al.
    Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.
    N Engl J Med 2017;377:1011-1021.

  3. Sondergaard L, Kasner SE, Rhodes JF, Andersen G, et al.
    Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.
    N Engl J Med 2017;377:1033-1042.

  4. Unalp-Arida A, Ruhl CE.
    Liver fibrosis scores predict liver disease mortality in the United States population.
    Hepatology 2017;66:84-95.

  5. Trickey A, May MT, Schommers P, Tate J, et al.
    CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC).
    Clin Infect Dis 2017;65:959-966.

  1. Rimola J, Diaz-Gonzalez A, Darnell A, Varela M, et al.
    Complete response under sorafenib in patients with hepatocellular carcinoma. Relationship with dermatologic adverse events.
    Hepatology 2017.

  2. McBride JM, Lim JJ, Burgess T, Deng R, et al.
    Safety and Efficacy of MHAA4549A, a Broadly Neutralizing Monoclonal Antibody, in a Human Influenza A Challenge Model: A Phase 2 Randomized Trial.
    Antimicrob Agents Chemother 2017.

  3. Seisen T, Vetterlein MW, Karabon P, Jindal T, et al.
    Efficacy of Local Treatment in Prostate Cancer Patients with Clinically Pelvic Lymph Node-positive Disease at Initial Diagnosis.
    Eur Urol 2017.

  4. Garg SK, Henry RR, Banks P, Buse JB, et al.
    Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes.
    N Engl J Med 2017.

  5. Han B, Compton WM, Blanco C, Crane E, et al.
    Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and Health.
    Ann Intern Med 2017;167:293-301.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016